Duchenne Muscular Dystrophy in Oman
How patients in Oman access treatment for duchenne muscular dystrophy via Named Patient Program.
About Duchenne Muscular Dystrophy
Neuromuscular
Treatment access in Oman
Oman's MoH operates a personal-import pathway; volumes are smaller but the pathway is functional for rare-disease and specialty needs.
For patients in Oman with duchenne muscular dystrophy whose required therapy is not locally registered, a Named Patient Program pathway typically applies.
How Reserve Meds supports patients with duchenne muscular dystrophy in Oman
- Patient or physician contacts us with disease details and therapy requested.
- We verify eligibility in Oman and confirm US supply.
- Treating physician in Oman issues prescription and justification.
- We file Oman-specific NPP/personal-import paperwork.
- We source the drug from a DSCSA-compliant US specialty wholesaler.
- Cold-chain shipment to the patient's physician or hospital pharmacy in Oman.
Patient support throughout
- Case manager from request through delivery.
- Documentation translation where needed.
- Physician-to-physician support for clinical justification.
- Re-supply coordination for chronic therapy.